NASDAQ: ARCTArcturus Therapeutics Holdings Inc Stock Ownership - Who owns Arcturus Therapeutics Holdings?
Insider buying vs selling
Have Arcturus Therapeutics Holdings Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Pad Chivukula | Chief Scientific Officer COO | 2024-03-25 | 17,435 | $35.02 | $610.57kSell |
| Pad Chivukula | Chief Scientific Officer COO | 2024-03-19 | 8,565 | $35.01 | $299.84kSell |
| Pad Chivukula | Chief Scientific Officer COO | 2023-11-01 | 5,000 | $18.72 | $93.60kSell |
| Pad Chivukula | Chief Scientific Officer COO | 2023-10-02 | 5,000 | $25.61 | $128.06kSell |
| Pad Chivukula | Chief Scientific Officer COO | 2023-09-01 | 5,000 | $31.45 | $157.27kSell |
| Andy Sassine | Chief Financial Officer | 2023-08-15 | 1,223 | $17.37 | $21.25kBuy |
| Pad Chivukula | Chief Scientific Officer COO | 2023-08-01 | 5,000 | $34.91 | $174.55kSell |
| Pad Chivukula | Chief Scientific Officer COO | 2023-07-14 | 25,000 | $35.01 | $875.25kSell |
| Keith C. Kummerfeld | Senior Vice President of Finance Principal Accounting Officer | 2023-07-14 | 4,500 | $9.04 | $40.68kBuy |
| Keith C. Kummerfeld | Senior Vice President of Finance Principal Accounting Officer | 2023-07-14 | 6,968 | $35.00 | $243.88kSell |
ARCT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ARCT insiders and whales buy or sell their stock.
ARCT Shareholders
What type of owners hold Arcturus Therapeutics Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Federated Hermes Inc | 17.50% | 4,711,512 | $130.23M | Institution |
| Blackrock Inc | 8.91% | 2,398,296 | $66.29M | Institution |
| Ark Investment Management LLC | 7.61% | 2,047,687 | $56.60M | Institution |
| State Street Corp | 6.05% | 1,629,666 | $45.04M | Institution |
| Joseph E. Payne | 5.50% | 1,480,097 | $40.91M | Insider |
| Vanguard Group Inc | 5.42% | 1,458,380 | $40.31M | Institution |
| Ultragenyx Pharmaceutical Inc | 5.20% | 1,400,000 | $38.70M | Insider |
| Nikko Asset Management Americas Inc | 4.91% | 1,320,652 | $36.50M | Institution |
| Sumitomo Mitsui Trust Holdings Inc | 4.91% | 1,320,652 | $36.50M | Institution |
| Dimensional Fund Advisors LP | 4.05% | 1,088,930 | $30.10M | Institution |
ARCT vs Biotech Stocks
Arcturus Therapeutics Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.